The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review

Current Pharmaceutical Design

Volumn 16, Issue 26, 2010, Pages 2935-2947

  Hasani Ranjbar, Shirin ^a   Nayebi, Neda ^a   Moradi, Leila ^a   Mehri, Avin ^a   Larijani, Bagher ^a   Abdollahi, Mohammad ^a,b  

^a Faculty of Medicine   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Extract plant; Herbal medicine; Hyperlipidemia; Medicine traditional

Indexed keywords

ACHILLEA WILHELMSII EXTRACT; BLACK TEA EXTRACT; CHOLESTEROL; CHUNGHYUL DAN; COMMIPHORA MUKUL EXTRACT; CREATININE; DAMING CAPSULE; GARLIC EXTRACT; GARLIC OIL; GLUCOSE; GLYCYRRHIZA GLABRA EXTRACT; GREEN TEA EXTRACT; HACHIMIJIOGAN; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONASCUS PURPUREUS EXTRACT; NINGZHI CAPSULE; PHYTOSTEROL; PRIMROSE OIL; RHUBARB EXTRACT; SATUREJA KHUZESTANICA EXTRACT; SHANZHA XIAOZHI CAPSULE; SILYBUM MARIANUM EXTRACT; TERMINALIA ARJUNA EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TRIGONELLA FOENUM GRAECUM EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL DISCOMFORT; ABSENCE OF SIDE EFFECTS; ACHILLEA WILHELMSII; BLACK CURRANT; CHERRY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMMIPHORA; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; EMBLICA OFFICINALIS; EPIGASTRIC DISCOMFORT; FENUGREEK; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLYCYRRHIZA; HERB; HERBAL MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INTESTINE OBSTRUCTION; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MONASCUS; MYALGIA; NONHUMAN; ODOR; PATIENT COMPLIANCE; PRIORITY JOURNAL; RASH; REVIEW; SATUREJA KHUZESTANICA; SIDE EFFECT; SYSTEMATIC REVIEW; THYROID DISEASE; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

EID: 78649910374     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793176464     Document Type: Review

References (90)

1. Centers for disease control and prevention (CDC).Coronary heart disease mortality trends among whites and blacks--Appalachia and United States, 1980-1993. MMWR Morb Mortal Wkly Rep 1998; 47: 1005-1008
2. Wilson PW. Established risk factors and coronary artery disease: The framingham study. Am J Hypertens 1994; 7: 7S-12S
3. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47
4. Manolio TA, Pearson TA, Wenger NK, et al. Cholesterol and heart disease in older persons and women. Review of an NHLBI work-shop. Ann Epidemiol 1992; 2: 161
5. Larsen ML, Illingworth DR. Drug treatment of dyslipoproteinemia. Med Clin North Am 1994; 78: 225-45
6. Levy RI, Troendle AJ, Fattu JM. A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin. Circulation 1993; 87: III45-53
7. Hadjibabaie M, Gholami K, Khalili H, et al. Comparative efficacy and safety of atorvastatin, simvastatin, and lovastatin in the management of dyslipidemic type-2 diabetic patients. Therapy 2006; 3: 759-64
8. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 2004; 164: 1427-36
9. Fruchart JC, Brewer HB, Leitersdorf E. Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Am J Cardiol 1998; 81: 912-7
10. Davidson MH, Dillon MA, Gordon B, et al. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 1999; 159: 1893-1900
11. Shepherd J, Packard CJ, Morgan HG, et al. The effects of cholestyramine on high density lipoprotein metabolism. Atherosclerosis 1979; 33: 433-44
12. Insull W Jr, Toth P, Mullican W, et al. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: A 24-week randomized controlled trial. Mayo Clin Proc 2001; 76: 971-82
13. Illingworth DR, Stein EA, Mitchel YB, et al. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Arch Intern Med 1994; 154: 1586-95
14. Grundy SM, Mok HY, Zech L, Berman M. Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 1981; 22: 24
15. Probstfield JL, Hunninghake DB. Nicotinic acid as a lipoprotein-altering agent. Therapy directed by the primary physician. Arch Intern Med 1994; 154: 1557. doi: 10.1001/archinte.154.14.1557
16. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000; 160: 459-67
17. Hasani-Ranjbar s, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch Med Sci 2008; 4, 3: 285-92
18. Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009; 15(25): 3073-85
19. Vogel JH, Bolling SF, Costello RB, et al. Integrating complementary medicine into cardiovascular medicine. A report of the american college of cardiology foundation task force on clinical expert consensus documents (writing committee to develop an expert consensus document on complementary and integrative medicine). J Am Coll Cardiol 2005; 46: 184-21
20. Varady KA, Jones PJ. Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels? J Nutr 2005; 135: 1829-35
21. Singh BB, Vinjamury SP, Der-Martirosian C, et al. Ayurvedic and collateral herbal treatments for hyperlipidemia: a systematic review of randomized controlled trials and quasi-experimental designs. Altern Ther Health Med 2007; 13(4): 22-8
22. Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 2009; 150(12): 830-9
23. Jing A, Li-Mei Z, Yan-Jie L, Ben-Zhi C, Yong Z, Bao-Feng Y. A randomized, multicentre, open-label, parallel-group trial to compare the efficacy and safety profile of daming capsule in patients with hypercholesterolemia. Phytother Res 2009; 23(7): 1039-42
24. Nohr LA, Rasmussen LB, Straand J. Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study. Complement Ther Med 2009; 17(1): 16-22
25. Philippe O, Szapary MD, Megan L, et al. Guggulipid for the treatment of hypercholesterolemia a randomized controlled trial. JAMA 2003; 290: 765-72
26. Cho KH, Kang HS, Jung WS, Park SU, Moon SK Efficacy and safety of chunghyul-dan (qingwie-dan) in patients with hypercholesterolemia. Am J Chin Med 2005; 33(2): 241-8
27. Simons LA, Balasubramaniam S, von Konigsmark M, Parfitt A, Simons J, Peters W. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 1995; 113(2): 219-25
28. Isaacsohn JL, Moser M, Stein EA et al. powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998; 158(11): 1189-94
29. Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. JAMA 1998; 279(23): 1900-2
30. Fuhrman B, Volkova N, Kaplan M, et al. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure. Nutrition 2002; 18(3): 268-73
31. Fujita H, Yamagami T. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 2008; 28(7): 450-6
32. Sobenin IA, Andrianova IV, Demidova ON, Gorchakova T, Orek-hov AN. Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study. J Atheroscler Thromb 2008; 15(6): 334-8
33. Davies MJ, Judd JT, Baer DJ, et al. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 2003; 133(10): 3298S-302S
34. Maron DJ, Lu GP, Cai NS, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 2003 23; 163(12): 1448-53
35. Weidner C, Krempf M, Bard JM, Cazaubiel M, Bell D. Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia. Lipids Health Dis 2008; 7: 35
36. Vosough-Ghanbari S, Rahimi R, Kharabaf S, et al. Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial. Evid Based Complement Alternat Med 2010; 7: 465-70
37. Lin CC, Li TC, Lai MM. Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. Eur J Endocrinol 2005; 153(5): 679-86
38. Gheith O, Sheashaa H, Abdelsalam M, Shoeir Z, Sobh M. Efficacy and safety of Monascus purpureus Went rice in children and young adults with secondary hyperlipidemia: a preliminary report. Eur J Intern Med 2009; 20(3): e57-61
39. Prasanna, M. Hypolipidemic effect of fenugreek: A clinical study. Indian J Pharmacol 2000; 32(1): 34-36
40. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 1994; 8(4): 659-64
41. Oosthuizen1 W, Scholtz1 CS, Vorster1 HH, Jerling1 JC, Vermaa WJH. Extruded dry beans and serum lipoprotein and plasma haemostatic factors in hyperlipidaemic men. Eur J Clin Nutr 2000; 54: 373-9
42. Asgary S, Naderi GH, Sarrafzadegan N, Mohammadifard N, Mostafavi S, Vakili R. Antihypertensive and antihyperlipidemic effects of Achillea wilhelmsii. Drugs Exp Clin Res 2000; 26(3): 89-93
43. Gupta R, Singhal S, Goyle A, Sharma VN. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. J Assoc Physicians India 2001; 49: 231-235
44. McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1998; 152 (11): 1089-94
45. Huseini HF, Larijani B, Fakhrzadeh H, et al. The clinical trial of Silybum marianum seed extract (Silymarin) on type II diabetic patient with hyperlipidemia. Iran J Diab Lipid disord 2004; 3: 78
46. Rafieian M, Shahrani M, Pilehvarian AA, et al. Effect of Kelussia odoratissima Mozaffarian (KOM) on hyperlipidemia: a clinical trial study. J Shahrekord Univ Med Sci 2009; 10(4 suppl 1): 70-6
47. Gao F, Hu XF. Effect of Taizhi'an capsule combined with Simvastatin on hyperlipidemia in diabetic patients. Chin J Integr Med 2006; 12(1): 24-8
48. Li QL, Zhang YF. Clinical observation on effect of taizhi'an capsule in treating 150 patients with hyperlipidemia. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003; 23(5): 335-7
49. Tian GQ, Liang XC, Guo SS, et al. Effect of Ningzhi capsule on blood lipid spectrum in type 2 diabetes mellitus patients complicated with hyperlipidemia. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28(2): 118-21
50. Wu XL, Wang MJ, Kuang Y, Zhang WJ, Ao QX. A clinical research of Naoxinqing tablet's effects on blood fat and viscosity. Zhong Yao Cai 2008; 31(1): 171-4
51. Zhang SJ, Cheng ZX, Lin YW, Qin J, Cheng YH, Liu SL. Effection of compositie salviae dropping pill on hyperlipemia patients with phlegm and blood stasis syndrome. Zhongguo Zhong Yao Za Zhi 2007; 32(5): 440-3
52. Zhao HY, Wang WH. The effect of shanzha xiaozhi capsule on the blood lipid and the function of endothelial cells in patients with dislipidemia. Zhong Yao Cai 2006; 29(6): 629-31
53. Gardner CD, Chatterjee LM, Carlson JJ. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis 2001; 154(1): 213-20
54. Andallu B, Radhika B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J Exp Biol 2000; 38(6): 607-9. PMid: 11116534
55. Mel'chinskaia EN, Gromnatski NI, Kirichenko LL. Hypolipidemic effects of alisat and lipostabil in patients with diabetes mellitus. Ter Arkh 2000; 72(8): 57-8
56. Superko HR, Krauss RM. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol 2000; 35(2): 321-6
57. Goel V, Ooraikul B, Basu TK; cholesterol lowering effects of rhubarb stalk fiber in hypercholesterolemic men; J Am Coll Nutr. 1997; 16(6): 600-4
58. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996; 64(6): 866-70
59. Neil HA, Silagy CA, Lancaster T, et al. Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Physicians Lond 1996; 30(4): 329-34
60. Kenzelmann R, Kade F. Limitation of the deterioration of lipid parameters by a standardized garlic-ginkgo combination product. A multicenter placebo-controlled double-blind study. Arzneimittelforschung 1993; 43(9): 978-81
61. Jain AK, Vargas R, Gotzkowsky S, McMahon FG. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 1993; 94(6): 632-5
62. Holzgartner H, Schmidt U, Kuhn U. Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate. Arzneimittelforschung 1992; 42(12): 1473-7
63. Rotzsch W, Richter V, Rassoul F, Walper A. Postprandial lipemia under treatment with Allium sativum. Controlled double-blind study of subjects with reduced HDL2-cholesterol. Arzneimittelforschung 1992; 42(10): 1223-7
64. Mader FH. Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the german association of general practitioners' multicentric placebo-controlled double-blind study. Arzneimittelforschung 1990; 40(10): 1111-6
65. Vorberg G, Schneider B. Therapy with garlic: results of a placebo-controlled, double-blind study. Br J Clin Pract Suppl 1990; 69: 7-11
66. Auer W, Eiber A, Hertkorn E, et al. Hypertension and hyperlipidaemia: garlic helps in mild cases. Br J Clin Pract Suppl 1990; 69: 3-6
67. Brosche T, Platt D, Dorner H. The effect of a garlic preparation on the composition of plasma lipoproteins and erythrocyte membranes in geriatric subjects. Br J Clin Pract Suppl 1990; 69: 12-9
68. Luley C, Lehmann-Leo W, Möller B, Martin T, Schwartzkopff W. Lack of efficacy of dried garlic in patients with hyperlipoproteinemia. Arzneimittelforschung 1986; 36(4): 766-8
69. Yoshida H, Kusukawa R, Watanabe N, Ohtsuki G, Sakamoto T, Haranaka R. The effects of Ba-wei-wan (hachimijiogan) on plasma levels of high density lipoprotein-cholesterol and lipoperoxide in aged individuals. Am J Chin Med 1985; 13(1-4): 71-6
70. Bordia A, Bansal HC, Arora SK, Singh SV. Effect of the essential oils of garlic and onion on alimentary hyperlipemia. Atherosclerosis 1975; 21(1): 15-9
71. Falah-Hosseini H, Heshmat R, Mohseni F, et al. The Efficacy of Rheum ribes L. stalk extract on lipid profile in hypercholesterolemic type ii diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. J Med Plants 2008; 7(27): 92-97
72. Shen Xiao-Xu, LU Wei-Xing, MAO Jing-Yuan. Clinical study on 230 cases of hyperlipidemia with Qingzhi liutong wan. Chinese J of Information on TCM. 2005-04
73. Parastouei K, Ravanshad Sh, Mostafavi H, Setoudeh Maram E. Effects of garlic tablet on blood sugar, plasma lipids and blood pressure in type 2 diabetic patients with hyperlipidemia. J Med plants 2006; 5(supplement): 9-16
74. Yazdani K, Fotouhi A, Ala-Aldini F, et al. Comparison of therapeutic and short course side effects of Anethum graveolens l. (dill) with other common antihyperlipidemic drugs and placebo in combined hyperlipidemia: a double blind, randomized clinical trial. J Med Plants 2002; 1(3): 0-0
75. Jinzhou T, Jianhua D, Huaitang D, et al. A single-blind, positive controlled trial of Jingmingdan granule as a treatment for presenile and senile patients with hyperlipidemia and/or hyperlipoproteinemia. J Beijing Univ Trad Chin Med 1999; 06
76. Heber D, Yip I, Ashley JM, et al. Cholesterol-lowering effects of a proprietary chinese red-yeast-rice dietary supplement. Am J Clin Nutr 1999; 69: 231-6
77. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 1993; 119: 599
78. Gardner CD, Lawson LD, Block E, et al. Effect of raw garlic vs. commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med 2007; 167: 325-6
79. Rahimi R, Ghiasi S, Azimi H, Fakhari S, Abdollahi M. A review of the herbal phosphodiesterase inhibitors; Future perspective of new drugs. Cytokine 2010; 49: 123-129
80. Mohseni-Salehi-Monfared SS, Vahidi H, Abdolghaffari AH, Nikfar S, Abdollahi M. Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: A systematic review. World J Gastroenterol 2009; 28; 15(36): 4481-90
81. Mohseni-Salehi-Monfared SS, Larijani B, Abdollahi M. Islet transplantation and antioxidant management: A comprehensive review. World J Gastroenterol 2009; 15(10): 1153-61
82. Rahimi R, Mozaffari S, Abdollahi M. On the use of herbal medicines in management of inflammatory bowel diseases: A systematic review of animal and human studies. Dig Dis Sci 2009; 54: 471-80
83. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59(7): 365-73
84. Abdollahi M, Ranjbar A, Shadnia S, Nikfar S, Rezaiee A. Pesticides and oxidative stress: a review. Med Sci Monit 2004; 10(6): RA144-7
85. Yousefzadeh G, Larijani B, Mohammadirad A, et al. Determination of oxidative stress status and concentration of TGF-1 in the blood and saliva of osteoporotic subjects. Ann NY Acad Sci 2006; 1091: 142-50
86. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 2007; 52: 2015-21
87. Clifford M. Chlorogenic acids and other cinnamatesnature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 2000; 80: 1033-43
88. Englisch W, Beckers C, Unkauf M, Ruepp M, Zinserling V. Efficacy of artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 2000; 50: 260-5
89. Panizzi L, Scarpati ML. Constitution of cynarine, the active principle of the artichoke. Nature 1954; 174: 1062-3
90. Wider B, Pittler MH, Thompson-Coon J, Ernst E. Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst Rev 2009; 4: CD003335.